AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Vitrafy Life Sciences Ltd

3.670

-0.120-3.17%

Volume:26.59K

Turnover:96.86K

Market Cap:279.50M

PE:-14.58

High:3.800

Open:3.800

Low:3.590

Close:3.790

52wk High:4.660

52wk Low:1.160

Shares:76.16M

Float Shares:33.74M

Volume Ratio:0.45

T/O Rate:0.08%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.252

EPS(LYR):-0.252

ROE:-46.29%

ROA:-27.94%

PB:6.80

PE(LYR):-14.58

Loading ...

Overview Company News Filings

Australia's Vitrafy Life Sciences Gains on Entering US Market

Vitrafy Life Sciences Ltd - Enters U.S. Cell & Gene Therapy Market with Charter Medical Agreement

THOMSON REUTERS

Vitrafy Life Sciences Posts FY Operating Loss of A$14.6 Million

Vitrafy Life Sciences Ltd - FY Operating Loss A$14.6 Mln

THOMSON REUTERS

Vitrafy Life Sciences Enters Partnership with US Blood Bank to Expand Cryopreservation Ecosystem for Red Blood Cells, Shares Jump 11%

MT Newswires Live

Vitrafy Life Sciences Ltd - Vitrafy Enters a Partnership with Hoxworth Blood Center

THOMSON REUTERS

Vitrafy Life Sciences Ltd-results of Oversubscribed Share Purchase Plan

THOMSON REUTERS

Vitrafy Life Sciences Opens AU$2 Million Share Purchase Plan

MT Newswires Live

Vitrafy Life Sciences Ltd-Vitrafy Share Purchase Plan Opens - Spp Offer Booklet

THOMSON REUTERS

BUZZ-Australia's Vitrafy Life Sciences slumps on discounted placement

Vitrafy Life Sciences to Raise AU$30 Million via Placement; Shares Down 20%

MT Newswires Live

BRIEF-Vitrafy Life Sciences Receives Firm Commitments For A$30 Million Placement

Vitrafy Life Sciences - Firm Commitments Received for a$30 Mln Placement at Price of a$2.60 per Share

THOMSON REUTERS

BRIEF-Vitrafy Life Sciences Seeks Trading Halt

Vitrafy Life Sciences - Trading Halt Requested Pending Equity Capital Raising Announcement

THOMSON REUTERS

Vitrafy Life Sciences Partners With Vitalant Innovation Center on Red Blood Cell Preservation Technology

MT Newswires Live

Vitrafy Life Sciences Ltd - Vitrafy Enters a Partnership With Vitalant Innovation Center

THOMSON REUTERS

Vitrafy Life Sciences - and Vitalant to Configure Cryopreservation for Red Blood Cells

THOMSON REUTERS

EcoGraf And 2 Other ASX Penny Stocks To Watch Closely

Simply Wall St.

Vitrafy Life Sciences's Cryopreservation Ecosystem Used In USAISR's Phase Two Platelet Cryopreservation Study, Shares Rise 5%

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/VFY.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"VFY.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"VFY.AU\",,,,,undefined,":{"symbol":"VFY.AU","market":"AU","secType":"STK","nameCN":"Vitrafy Life Sciences Ltd","latestPrice":3.67,"timestamp":1789020720000,"preClose":3.79,"halted":0,"volume":26594,"delay":0,"changeRate":-0.03166226912928763,"nameEN":"Vitrafy Life Sciences Ltd","floatShares":33735952,"shares":76157278,"eps":-0.2518,"marketStatus":"Not Yet Opened","change":-0.12,"latestTime":"09-10 16:12:00 AEST","open":3.8,"high":3.8,"low":3.59,"amount":96862,"amplitude":0.055409,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.2518,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1789084800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":3.79,"openAndCloseTimeList":[[1788998400000,1789020000000]],"volumeRatio":0.44584150524734734,"lotSize":0,"tradeCurrency":"AUD","auctionPricing":{"symbol":"VFY.AU","preClose":3.79,"auctionPrice":3.67,"auctionVolume":17,"auction":3,"marketStatus":"盘后竞价","timestamp":1789020585312}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"VFY.AU\",,,,,undefined,":{"symbol":"VFY.AU","floatShares":33735952,"roa":"-27.94%","roe":"-46.29%","lyrEps":-0.2518,"volumeRatio":0.44584150524734734,"shares":76157278,"dividePrice":0,"high":3.8,"amplitude":0.055409,"preClose":3.79,"low":3.59,"week52Low":1.16,"pbRate":"6.80","psRate":"1337.33","week52High":4.66,"institutionHeld":0,"latestPrice":3.67,"eps":-0.2518,"divideRate":0,"volume":26594,"delay":0,"ttmEps":-0.2518,"open":3.8,"prevYearClose":1.28,"prevWeekClose":3.87,"prevMonthClose":3.85,"prevQuarterClose":3.01,"fiveDayClose":3.93,"twentyDayClose":4.17,"sixtyDayClose":2.76},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VFY.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-04","symbol":"VFY.AU","type":"earning","reportTimeType":"pre","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1785801600000,"name":null,"time":"Pre-MKt","dateTimestamp":1785765600000,"actualEps":null},{"date":"2026-04-28","symbol":"VFY.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1777334400000,"name":null,"time":"","dateTimestamp":1777298400000,"actualEps":null},{"date":"2026-02-03","symbol":"VFY.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1770073200000,"name":null,"time":"","dateTimestamp":1770037200000,"actualEps":null},{"date":"2025-10-21","symbol":"VFY.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1761001200000,"name":null,"time":"","dateTimestamp":1760965200000,"actualEps":null},{"date":"2025-08-05","symbol":"VFY.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1754352000000,"name":null,"time":"","dateTimestamp":1754316000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VFY.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VFY.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664893380","title":"Australia's Vitrafy Life Sciences Gains on Entering US Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2664893380","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664893380?lang=en_us&edition=fundamental","pubTime":"2026-09-02 11:10","pubTimestamp":1788318627,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Vitrafy Life Sciences gains on entering US market** Shares of Australia's Vitrafy Life SciencesVFY.AXrise as much as 6.7% to A$4.110, hitting their highest level since August 24** Cel","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nL4N44U09J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7048","VFY.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664886441","title":"Vitrafy Life Sciences Ltd - Enters U.S. Cell & Gene Therapy Market with Charter Medical Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2664886441","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664886441?lang=en_us&edition=fundamental","pubTime":"2026-09-02 07:17","pubTimestamp":1788304672,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nFWN44T15V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7048","VFY.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656852125","title":"Vitrafy Life Sciences Posts FY Operating Loss of A$14.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2656852125","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656852125?lang=en_us&edition=fundamental","pubTime":"2026-08-04 09:26","pubTimestamp":1785806787,"startTime":"0","endTime":"0","summary":"BRIEF-Vitrafy Life Sciences Posts FY Operating Loss Of A$14.6 MillionAug 4 (Reuters)-Vitrafy Life Sciences LtdVFY.AX:FY OPERATING LOSS A$14.6 MILLIONFurther company coverage:VFY.AX","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nFWN4401MC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7048","VFY.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656557300","title":"Vitrafy Life Sciences Ltd - FY Operating Loss A$14.6 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2656557300","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656557300?lang=en_us&edition=fundamental","pubTime":"2026-08-04 06:24","pubTimestamp":1785795887,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nFWN4401MC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VFY.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653792217","title":"Vitrafy Life Sciences Enters Partnership with US Blood Bank to Expand Cryopreservation Ecosystem for Red Blood Cells, Shares Jump 11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653792217","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653792217?lang=en_us&edition=fundamental","pubTime":"2026-07-23 08:53","pubTimestamp":1784768019,"startTime":"0","endTime":"0","summary":"Vitrafy Life Sciences  entered a partnership with Hoxworth Blood Center in the US to expand the firm's cryopreservation ecosystem in response to the end-of-life of legacy red blood cell cryopreservation technology, according to a Thursday Australian bourse filing.The firm said it was working to address red blood cell cryopreservation workflows resulting from the discontinuation of critical legacy technology starting in 2027. The agreement is not expected to generate revenue.Under the partnership, Vitrafy and Hoxworth will both contribute resources and support in addressing this threat. Vitrafy will initially place one cryopreservation freezing and software package at Hoxworth during the first half of fiscal year 2027.Its shares jumped 11% in recent trading on Thursday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["VFY.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653279187","title":"Vitrafy Life Sciences Ltd - Vitrafy Enters a Partnership with Hoxworth Blood Center","url":"https://stock-news.laohu8.com/highlight/detail?id=2653279187","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653279187?lang=en_us&edition=fundamental","pubTime":"2026-07-23 06:29","pubTimestamp":1784759367,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nFWN43O0OY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7048","VFY.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649533469","title":"Vitrafy Life Sciences Ltd-results of Oversubscribed Share Purchase Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2649533469","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649533469?lang=en_us&edition=fundamental","pubTime":"2026-07-08 06:25","pubTimestamp":1783463115,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nTUE6CC0H8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VFY.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644037265","title":"Vitrafy Life Sciences Opens AU$2 Million Share Purchase Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2644037265","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644037265?lang=en_us&edition=fundamental","pubTime":"2026-06-19 09:16","pubTimestamp":1781831807,"startTime":"0","endTime":"0","summary":"Vitrafy Life Sciences  said its non-underwritten share purchase plan targeting proceeds of about AU$2 million is now open and will run until July 3, according to a Friday filing with the Australian bourse.The plan is open to shareholders of record as of June 11 at a price of AU$2.60 per share.The company's shares rose past 1% in recent Friday trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["VFY.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644343310","title":"Vitrafy Life Sciences Ltd-Vitrafy Share Purchase Plan Opens - Spp Offer Booklet","url":"https://stock-news.laohu8.com/highlight/detail?id=2644343310","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644343310?lang=en_us&edition=fundamental","pubTime":"2026-06-19 06:20","pubTimestamp":1781821231,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nTUEBCJB2V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VFY.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642105254","title":"BUZZ-Australia's Vitrafy Life Sciences slumps on discounted placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2642105254","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642105254?lang=en_us&edition=fundamental","pubTime":"2026-06-12 13:30","pubTimestamp":1781242209,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Vitrafy Life Sciences slumps on discounted placement** Shares of Vitrafy Life Sciences VFY.AX fall as much as 21.3% to A$2.99, marking their biggest pct loss ever** Cryopreservation solution developer announces A$30 million  institutional placement at A$2.60 per share, a 46.2% discount to last close ** About 245,052 shares traded so far, 4.3x 30-day average** Stock last down 13.7% with YTD gains of 156.3%","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260612:nL4N42K0B9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VFY.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642533792","title":"Vitrafy Life Sciences to Raise AU$30 Million via Placement; Shares Down 20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2642533792","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642533792?lang=en_us&edition=fundamental","pubTime":"2026-06-12 09:02","pubTimestamp":1781226141,"startTime":"0","endTime":"0","summary":"Vitrafy Life Sciences  received firm commitments to raise AU$30 million through the issue of about 11.5 million new shares at AU$2.60 apiece, according to a Friday filing with the Australian bourse.The company will also offer eligible shareholders the opportunity to participate in a non-underwritten shares purchase plan to raise up to a further AU$2 million at the same price as the placement, the filing said.Proceeds will be used to fund the manufacturing of Guardion devices, with additional funds deployed towards the expansion of US sales and operations, per the filing.Shares fell nearly 20% in morning trade Friday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["VFY.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642304442","title":"BRIEF-Vitrafy Life Sciences Receives Firm Commitments For A$30 Million Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2642304442","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642304442?lang=en_us&edition=fundamental","pubTime":"2026-06-12 07:52","pubTimestamp":1781221975,"startTime":"0","endTime":"0","summary":"BRIEF-Vitrafy Life Sciences Receives Firm Commitments For A$30 Million Placement June 12 (Reuters) - Vitrafy Life Sciences Ltd VFY.AX:FIRM COMMITMENTS RECEIVED FOR A$30 MILLION PLACEMENT AT PRICE OF A$2.60 PER SHAREFurther company coverage: VFY.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nFWN42J0OK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VFY.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642230616","title":"Vitrafy Life Sciences - Firm Commitments Received for a$30 Mln Placement at Price of a$2.60 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2642230616","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642230616?lang=en_us&edition=fundamental","pubTime":"2026-06-12 07:33","pubTimestamp":1781220824,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nFWN42J0OK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VFY.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642418767","title":"BRIEF-Vitrafy Life Sciences Seeks Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2642418767","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642418767?lang=en_us&edition=fundamental","pubTime":"2026-06-10 06:34","pubTimestamp":1781044478,"startTime":"0","endTime":"0","summary":"BRIEF-Vitrafy Life Sciences Seeks Trading HaltJune 10 (Reuters) - Vitrafy Life Sciences Ltd VFY.AX:TRADING HALT REQUESTED PENDING EQUITY CAPITAL RAISING ANNOUNCEMENTFurther company coverage: VFY.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nFWN42H0SY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7048","VFY.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642841873","title":"Vitrafy Life Sciences - Trading Halt Requested Pending Equity Capital Raising Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=2642841873","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642841873?lang=en_us&edition=fundamental","pubTime":"2026-06-10 06:32","pubTimestamp":1781044345,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nFWN42H0SY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7048","VFY.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640551995","title":"Vitrafy Life Sciences Partners With Vitalant Innovation Center on Red Blood Cell Preservation Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2640551995","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640551995?lang=en_us&edition=fundamental","pubTime":"2026-06-02 09:12","pubTimestamp":1780362756,"startTime":"0","endTime":"0","summary":"Vitrafy Life Sciences  has partnered with US healthcare organization Vitalant Innovation Center to address a \"looming crisis\" for red blood cell preservation, according to a Tuesday filing with the Australian bourse.The companies aim to configure Vitrafy's cryopreservation ecosystem as a successor to legacy technology and products that will be discontinued from 2027, which poses a threat to red blood cell stockpiles, per the filing.To support that objective, Vitrafy will initially place two cryopreservation freezing units at the Vitalant Innovation Center in Denver. The placement will not generate revenue, but the company expects the collaboration \"to support broader market and government engagement toward a unified response,\" it said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7048","VFY.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640998447","title":"Vitrafy Life Sciences Ltd - Vitrafy Enters a Partnership With Vitalant Innovation Center","url":"https://stock-news.laohu8.com/highlight/detail?id=2640998447","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640998447?lang=en_us&edition=fundamental","pubTime":"2026-06-02 08:08","pubTimestamp":1780358939,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nFWN42910X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VFY.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640984409","title":"Vitrafy Life Sciences - and Vitalant to Configure Cryopreservation for Red Blood Cells","url":"https://stock-news.laohu8.com/highlight/detail?id=2640984409","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640984409?lang=en_us&edition=fundamental","pubTime":"2026-06-02 08:08","pubTimestamp":1780358939,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nFWN42910X:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VFY.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638052039","title":"EcoGraf And 2 Other ASX Penny Stocks To Watch Closely","url":"https://stock-news.laohu8.com/highlight/detail?id=2638052039","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638052039?lang=en_us&edition=fundamental","pubTime":"2026-05-27 10:05","pubTimestamp":1779847536,"startTime":"0","endTime":"0","summary":"As the Australian market holds steady, awaiting crucial inflation data, investors are keenly observing potential opportunities amidst a backdrop of global volatility and local economic anticipation. Penny stocks, often seen as relics of past market eras, continue to offer intriguing prospects for those seeking growth at accessible price points. By focusing on companies with strong financial health and clear growth potential, investors can uncover hidden gems in this often overlooked segment...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-egr/ecograf-shares/news/ecograf-and-2-other-asx-penny-stocks-to-watch-closely","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-egr/ecograf-shares/news/ecograf-and-2-other-asx-penny-stocks-to-watch-closely","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BEAR.AU","GIVE.AU","GEAR.AU","VAP.AU","XAO.AU","DACE.AU","OZF.AU","OZR.AU","BBOZ.AU","IIGF.AU","BK7095","IISV.AU","UOS.AU","VFY.AU","QFN.AU","EIGA.AU","XJO.AU","BK7048","EGR.AU","IMLC.AU","E200.AU","STW.AU","ZYAU.AU","VAS.AU","XKO.AU","SLF.AU","QRE.AU","IOZ.AU","BK7121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625996561","title":"Vitrafy Life Sciences's Cryopreservation Ecosystem Used In USAISR's Phase Two Platelet Cryopreservation Study, Shares Rise 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625996561","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625996561?lang=en_us&edition=fundamental","pubTime":"2026-04-08 10:44","pubTimestamp":1775616251,"startTime":"0","endTime":"0","summary":"Vitrafy Life Sciences  said the US Army Institute of Surgical Research  completed the phase two testing of its platelet cryopreservation study using Vitrafy's cryopreservation ecosystem, according to a Wednesday Australian bourse filing.The study sought to confirm the consistency of earlier results and further characterise performance across multiple cryopreservation formulations. The work was carried out under the ongoing cooperative research and development agreement  between the firm and the US Army.Its shares rose 5% in recent trading on Wednesday.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["VFY.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":20,"code":"91000000","status":"200"}]}}